These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1864979)

  • 1. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
    Levy Y; Tsapis A; Brouet JC
    J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
    Keller ET; Ershler WB
    J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
    Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
    Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
    Schadendorf D; Möller A; Algermissen B; Worm M; Sticherling M; Czarnetzki BM
    J Immunol; 1993 Sep; 151(5):2667-75. PubMed ID: 8360485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism.
    Kong B; Isozaki T; Sasaki S
    Gynecol Oncol; 1996 Oct; 63(1):78-84. PubMed ID: 8898173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.
    Burch RM; Mahan LC
    J Clin Invest; 1991 Oct; 88(4):1190-6. PubMed ID: 1833422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
    Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
    Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
    Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
    Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides.
    Watson JM; Berek JS; Martínez-Maza O
    Gynecol Oncol; 1993 Apr; 49(1):8-15. PubMed ID: 8482564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
    Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
    Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR
    Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
    Bataille R; Klein B
    Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
    Takahashi T; Okuno Y; Ohsugi Y
    Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
    Kishima Y; Yoshida K; Enomoto H; Yamamoto M; Kuroda T; Okuda Y; Uyama H; Nakamura H
    Hepatogastroenterology; 2002; 49(48):1639-44. PubMed ID: 12397753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.
    Rogers SY; Bradbury D; Kozlowski R; Russell NH
    Exp Hematol; 1994 Jul; 22(7):593-8. PubMed ID: 7516889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel and rapid prediction assay for the effectiveness of IL-6 receptor specific antisense oligonucleotides by proliferation inhibition of an interleukin-6 dependent cell line.
    Lia Varga V; Falus A; Pallinger E; Novák I; Fülöp KA; Toth S; Rose-John S
    Cell Biol Int; 2001; 25(3):253-6. PubMed ID: 11352498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.
    Lu C; Sheehan C; Rak JW; Chambers CA; Hozumi N; Kerbel RS
    Clin Cancer Res; 1996 Aug; 2(8):1417-25. PubMed ID: 9816316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.